期刊文献+

MDM2、p53在卵巢肿瘤组织及细胞系的表达和意义 被引量:2

THE EXPRESSION AND MEANING OF MDM2、p53 PROTEIN IN OVARIAN TUMOR TISSUES AND CELL LINES
下载PDF
导出
摘要 目的 研究MDM 2 (murinedoubleminute 2 )和 p5 3在卵巢肿瘤组织、细胞系表达及与卵巢癌发生关系。 方法 ①用细胞培养、蛋白质提取、Western免疫印迹法检测 17个卵巢癌细胞系MDM 2、p5 3蛋白表达。②用免疫组化SP法检测卵巢良性上皮性肿瘤、卵巢交界性上皮性肿瘤和卵巢癌中MDM 2、p5 3蛋白的表达。结果 ① 17个卵巢癌细胞系MDM 2蛋白p90表达阳性率为 11 8% (2 / 17) ;p5 3的阳性表达率为 3 5 3 % (6/ 17) ,2例MDM 2表达阳性出现在野生型卵巢癌细胞株。②在卵巢良性上皮性肿瘤、卵巢交界性上皮性肿瘤和卵巢癌中MDM 2的阳性表达率分别为 :2 0 % (2 / 10 )、2 5 % (2 / 8)和 2 5 % (5 / 2 0 ) ;p5 3的阳性表达率分别为 2 0 % (2 / 10 )、3 7 5 % (3 / 8)和 60 % (12 / 2 0 )。 3组中 ,MDM 2阳性表达率无显著性差异 (P >0 0 5 ) ,而 p5 3在卵巢癌中的阳性表达率显著高于卵巢良性上皮性肿瘤和交界性上皮性肿瘤 (P <0 0 5 )。结论 p5 3的异常表达与卵巢肿瘤的恶性表型相关。在卵巢癌的发生发展过程中 ,p5 3的异常表达比MDM 2更有意义。MDM 2表达阳性可能在无 p5 3基因突变的卵巢癌细胞发生。 Objective: To study the expression and relationship of MDM2 and p53 protein in ovarian tumor tissues? ovarian cancer cell lines. Methods: Cell culture?protein extraction?Western blotting and immunohistochemistry were used. Results: The rate of position expression of MDM2 protein in 17 ovarian cancer cell lines was 11 8%(2/17); the rate of positive expression of p53 was 35 3%(6/17). Two cases of positive expression of MDM2 only appeared in wild type p53, no position in mutation type. In ovarian benign epithelial tumors, borderline epithelial tumors and malignant epithelial tumors, the positive rates of MDN2 and p53 were 20%, 25%, 25%; and 20%, 37 5%, 60% respectively. The positive detection of MDM2 between the three groups of ovarian tumors was not significantly different (P>0 05), but the expression of p53 in malignant epithelial tumors was significantly higher than those in the other groups (P<0 05). Conclusion: The expression of p53 correlates with the malignant phenotypes of ovarian epithelial tumors. In the pathogenesis and development of malignant ovarian epithelial tumors, the abnormal expression of p53 may be more significant than that of MDM2. MDM2 might play a role in the ovarian cancer without p53 mutation.
出处 《实用临床医药杂志》 CAS 2003年第5期453-455,共3页 Journal of Clinical Medicine in Practice
基金 国家自然科学资金项目 (No .3 9970 778) 江苏省科技厅资助课题 (BS2 0 0 3 63 9)
关键词 卵巢癌细胞系 卵巢肿瘤 MDM2蛋白 P53 表达 ovarian cancer cell Lines ovarian neoplasm MDM2 protein p53 expression, immunohistochemistry
  • 相关文献

参考文献8

  • 1Pietel J, Neel H, Marechol V, et al. Mdm2: Keeping p53 under control[J]. Oncogene, 1997, 15: 1001.
  • 2Mobus V, Gerharz C D, Pressu, et al. Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines [ J ]. Int J Cancer, 1992, 52: 76.
  • 3Harlozinsak A, Bar J, Montenarh M. Analysis of the immunoreactivity of three anti-p53 antibodies and estimation of the relations between 1353 status and MDM2 protein expression in ovarian carcinomas [ J ]. Anticancer Res, 2000, 20(2A) : 1049.
  • 4Takimoto R, Wang W, Dicker D T, et al. The mutant p53- conformation conformation drug, cp-31398, can induce apoptosis of human cancer cells and can stabilize wild-type p53 protein [J]. Cancer Biol Ther. 2002, 1(1): 47.
  • 5Jin X, Burke W, Rothman K. et al. Resistance to p53-mediated growth suppression in human ovarian cancer cells retain endogenous wild-type p53 [J]. Anticancer Res. 2002, 22 (2A) : 659.
  • 6Deborah A, Freedman, Levien, A J, et al. Regulation of the p53 protein by the MDM2 oncoprotein[J]. Cancer Research, 1999, 59: 1.
  • 7Yoshida Y, Hosokawa K, Dantes A, et al. Role of laminin in ovarian cancer tumor growth and metastasis via regulation of Mdm2 and Bcl-2 expression[J]. Int J Oncol. 2001, 18(5): 913.
  • 8Foulkes W D, Stomp Guh, Afzals, et al. MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status[J]. British Journal of cancer, 1995, 72: 883.

同被引文献17

  • 1张卫东,肖奇明,胡成平,陈琼.非小细胞肺癌细胞中VEGFR-3的表达及其临床意义[J].医学临床研究,2004,21(7):753-755. 被引量:1
  • 2Kubo H,Fujiwara T,Jussila L,et al.Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis[J].Blood,2000,96(2):546-553.
  • 3Tang RF,Itakura J,Aikawa T,et a1.Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer[J].Pancreas,2001,22(3):285-292.
  • 4Kaipainen A,Korhonen J,Mutonen T,et al.Expression of the fmslike tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development[J].Proc Matl Acad Sci USA,1995,92(8):3 566-3 570.
  • 5Krishnan J,Kirkin V,Steffen A,et al.Differential in vivo and in vitro expression of vascular endothelial growth factor(VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats[J].Cancer Res,2003,63(3):713-722.
  • 6Nakashima T,Kondoh S,Kitoh H,et al.Vascular endothelial growth factor-C expression in human gallbladder cancer and its relationship to lymph node metastasis[J].Int J Mol Med,2003,11(1):33-39.
  • 7Karkkainen MJ,Petrova TV.Vascular endothelial growth factor receptors in the regulation of angiogenesis and Lymphangiogenesis[J].Oncogene,2000,19(49):5 598-5 605.
  • 8Furudoi A,Tanaka S,Haruma K,et al.Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma[J].Oncology,2002,62(2):157-166.
  • 9Kabashima A,Maehara Y,Kakeji Y,et al.Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma[J].Oncology,2001,60(2):146-150.
  • 10Vermeulen K, Van Bockstaele DR, Bememan ZN. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer[ J ]. Cell Prolif,2003,36(3) : 131-149.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部